Trichomonas gallinae are parasitic flagellates of significance in wild and residential birds. The parasite is worldwide distributed, and Columbine birds are its foremost host. Current evaluation focuses completely on epidemiological and phylogenetic analysis. Nonetheless, there could also be nonetheless a lack of knowledge regarding parasite-host interaction or treatment development.

 

Precise-time PCR is a helpful gizmo for diagnostic and quantification of gene copies in a determined sample. By amplification of a 113-bp space of the 18S small subunit ribosomal RNA gene, a SYBR green-based real-time PCR assay was developed.

A daily curve was prepared for quantification analysis. Assay effectivity, linearity, and dissociation analysis have been effectively carried out. Specificity, sensibility, and reproducibility analysis have been examined. This assay is likely to be a helpful gizmo not only for diagnostic capabilities however moreover for future in vivo and in vitro T. gallinae analysis.

 

Enchancment of a standard RT-PCR assay for grapevine vitiviruses

The genus Vitivirus throughout the family Betaflexiviridae accommodates eleven viruses acknowledged to infect grapevine: grapevine vitiviruses A, B, D, E, F, G, H, I, J, L and M (GVA-GVM). Three of these viruses, GVA, GVB and GVD, have been associated to the etiology of rugose picket sickness in grapevine and set off agronomically important losses. The alternative vitiviruses have been additional simply currently discovered and their outcomes on grapevine are undetermined. To certify grape supplies for propagation as virus examined, an updated reverse transcription PCR (RT-PCR) assay to detect all acknowledged vitiviruses is fascinating.

To carry out this, various grapevine vitivirus sequences have been aligned on the amino acid diploma to hunt for conserved motifs. Two extraordinarily conserved motifs have been found at a superb distance for RT-PCR detection throughout the RNA-dependent RNA polymerase space of the replicase protein. The amino acid motifs have been once more translated to create degenerate primers and used to effectively amplify all eleven grapevine vitiviruses. The RT-PCR primers have been used to test a panel of vitivirus-infected vines for inclusivity along with vines contaminated with rigorously related viruses throughout the Betaflexiviridae family (i.e. grapevi

ne pinot gris virus and grapevine rupestris stem pitting-associated virus) for exclusivity. Broader use of these primers to detect vitiviruses in several plant hosts was investigated. In summary, an end-point RT-PCR assay that detects all the acknowledged grapevine vitiviruses and doubtless totally different members of the genus Vitivirus has been developed. The frequent assay represents another option to explicit individual assays to cut back the work associated to the prognosis of vitiviruses, along with for regulatory capabilities.

Pathologic full response (pCR) expenses and outcomes after neoadjuvantchemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction

Background: Pathologic full response (pCR) after neoadjuvantchemoradiotherapy (nCRT) is said to improved survival in victims dealt with for esophageal most cancers. Whereas proton beam treatment (PBT) has been demonstrated to cut back toxicities with nCRT, no data evaluating pCR expenses between modalities exist thus far. We investigated pCR expenses in victims with distal esophageal/GEJ adenocarcinomas current course of trimodality treatment with nCRT-PBT or photon-based nCRT with the hypothesis that pathologic responses with PBT is usually a minimal of as extreme as with photon treatment.

Methods: A single-institutional consider of victims with distal esophageal adenocarcinoma dealt with with trimodality treatment from 2015-2018 using PBT was achieved. PBT victims have been matched 1:2 to victims dealt with with photons. Chi sq. and two-sample t-tests have been utilized to test traits, and the Kaplan Meier method was used to estimate oncologic endpoints.

Outcomes: Eighteen consecutive PBT victims have been acknowledged and as compared with 36 photon victims. All victims obtained concurrent chemotherapy; 98% with carboplatin/paclitaxel. Most victims have been male (91%) and White (89%); median age was 62 years (range, 31-76 years). Median radiation dose in every cohorts was 50.4 Gy (range, 41.4-50.4 Gy); all applications have been delivered in 1.8Gy fractions. Age, gender and race have been successfully balanced.

Victims dealt with with PBT had a significantly better pre-treatment nodal stage (N) and AJCC 7^th model stage grouping (P=0.02, P=0.03). No matter this, tumoral and nodal clearance and pCR expenses have been equal between cohorts (P=0.66, P=0.11, P=0.63, respectively). Whole pCR and explicit individual principal and nodal clearance expenses, whole survival (OS), locoregional administration (LRC), and distant metastatic administration did not significantly differ between modalities (all P>0.05). Most important perioperative events have been balanced; nonetheless, there have been 5 (14%) perioperative deaths throughout the photon cohort as compared with 0 (0%) throughout the proton cohort (P=0.06).

Conclusions: Utilizing PBT in trimodality treatment for distal esophageal adenocarcinoma yields pCR expenses much like photon radiation and historic controls. Pathologic responses and oncologic outcomes on this analysis did not differ significantly between modalities no matter PBT victims having better AJCC ranges and nodal sickness burdens.

On this paper, we utilized a curved-channel microfluidic system to separate DNA from PCR-inhibitor-containing water and concurrently wash them into clear water for detection utilizing a transportable PCR thermocycler. Environmental DNA (eDNA) sampling has change into an efficient surveying strategy for detecting uncommon organisms. Nevertheless, low focus eDNA molecules could also be masked by PCR inhibitors throughout amplification and detection, growing the danger of false negatives. Due to this fact, applied sciences for on-site DNA separation and washing are urgently wanted. Our system consisted of a half-circle microchannel with a DNA-inhibitor pattern inlet, a clear buffer inlet, and a number of retailers.

Through the use of the flow-induced inertial forces, 10 μm DNA-conjugated microparticles had been centered on the inner-wall of the curved microchannel whereas separation from 1 μm inhibitor-conjugated microparticles and DNA washing had been achieved concurrently with the Dean move. We achieved singleplex focusing, isolation and washing of 10 μm particles at an effectivity of 94.5 ± 2.0%. In duplex experiments with 1 μm and 10 μm particles, bigger particles had been washed with an effectivity of 92.1 ± 1.6% and a purity of 79 ± 2%.

By surface-functionalizing the microparticles with affinity teams towards Atlantic salmon DNA and humic acid (HA), and processing samples of varied concentrations in our system, we achieved an efficient purification and detection of DNA molecules utilizing the transportable PCR thermocycler. Our methodology considerably decreased PCR quantitation cycles from Cq > 38 to Cq = 30.35 ± 0.5, which confirmed enhancement of PCR amplification. The proposed system takes a promising step ahead in pattern preparation in the direction of an built-in system that can be utilized for simultaneous purification and answer alternate of DNA in point-of-need environmental monitoring purposes.

GPR81 Antibody
R35411-100UG	NSJ Bioreagents	100 ug	EUR 399

Rabbit Polyclonal antibody Anti-CRBN
Anti-CRBN	ImmunoStep	50 µg	EUR 418.8

GPR81 Conjugated Antibody
C44942	SAB	100ul	EUR 476.4

Polyclonal Goat Anti-GPR81 / FKSG80 Antibody
APR16285G	Leading Biology	0.1 mg	EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR81 / FKSG80 . This antibody is tested and proven to work in the following applications:

GPR81 Peptide
42-015P	ProSci	0.1 mg	EUR 405.6
Description: (IN) GPR81 / FKSG80 Peptide

GPR81 Blocking Peptide
DF2766-BP	Affbiotech	1mg	EUR 234

GPR81 Blocking Peptide
20-abx063821	Abbexa	EUR 326.40 EUR 493.20	1 mg 5 mg

pDNR-Dual-GPR81
PVT17473	Lifescience Market	2 ug	EUR 277.2

Polyclonal GPR81 Antibody (C-term)
APR16611G	Leading Biology	0.1ml	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR81 (C-term). This antibody is tested and proven to work in the following applications:

GPR81 ELISA KIT|Human
EF009971	Lifescience Market	96 Tests	EUR 826.8

Polyclonal Goat anti-GST α-form
GST-ANTI-1	Detroit R&D	50 uL	EUR 336

Polyclonal Goat anti-GST μ-form
GST-ANTI-2	Detroit R&D	50 uL	EUR 336

Polyclonal Goat anti-GST p-form
GST-ANTI-3	Detroit R&D	50 uL	EUR 336

Polyclonal FKSG80 / GPR81 Antibody (C-Terminus)
APR15995G	Leading Biology	0.05mg	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal FKSG80 / GPR81 Antibody (Extracellular Domain)
APR15996G	Leading Biology	0.05mg	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Polyclonal FKSG80 / GPR81 Antibody (N-Terminus)
APR15997G	Leading Biology	0.05mg	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (N-Terminus). This antibody is tested and proven to work in the following applications:

Gpr81 ORF Vector (Rat) (pORF)
ORF067824	ABM	1.0 ug DNA	EUR 607.2

Gpr81 ORF Vector (Mouse) (pORF)
ORF046573	ABM	1.0 ug DNA	EUR 607.2

G Protein-Coupled Receptor 81 (GPR81) Antibody
20-abx147554	Abbexa	EUR 510.00 EUR 410.40	100 ug 50 ug

G Protein-Coupled Receptor 81 (GPR81) Antibody
20-abx008192	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx028676-400ul	Abbexa	400 ul	EUR 627.6

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx028676-80l	Abbexa	80 µl	EUR 343.2

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx233610-100ug	Abbexa	100 ug	EUR 661.2

G Protein-Coupled Receptor 81 (GPR81) Antibody
abx430538-200ul	Abbexa	200 ul	EUR 460.8

GPR81 sgRNA CRISPR Lentivector set (Human)
K0893201	ABM	3 x 1.0 ug	EUR 406.8

Gpr81 sgRNA CRISPR Lentivector set (Rat)
K6130201	ABM	3 x 1.0 ug	EUR 406.8

Gpr81 sgRNA CRISPR Lentivector set (Mouse)
K3904701	ABM	3 x 1.0 ug	EUR 406.8

GPR81 sgRNA CRISPR Lentivector (Human) (Target 1)
K0893202	ABM	1.0 ug DNA	EUR 184.8

GPR81 sgRNA CRISPR Lentivector (Human) (Target 2)
K0893203	ABM	1.0 ug DNA	EUR 184.8

GPR81 sgRNA CRISPR Lentivector (Human) (Target 3)
K0893204	ABM	1.0 ug DNA	EUR 184.8

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 1)
K6130202	ABM	1.0 ug DNA	EUR 184.8

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 2)
K6130203	ABM	1.0 ug DNA	EUR 184.8

Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6130204	ABM	1.0 ug DNA	EUR 184.8

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3904702	ABM	1.0 ug DNA	EUR 184.8

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3904703	ABM	1.0 ug DNA	EUR 184.8

Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3904704	ABM	1.0 ug DNA	EUR 184.8

GPR81 Protein Vector (Mouse) (pPB-C-His)
PV186290	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Mouse) (pPB-N-His)
PV186291	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Mouse) (pPM-C-HA)
PV186292	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Mouse) (pPM-C-His)
PV186293	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Rat) (pPB-C-His)
PV271294	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Rat) (pPB-N-His)
PV271295	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Rat) (pPM-C-HA)
PV271296	ABM	500 ng	EUR 723.6

GPR81 Protein Vector (Rat) (pPM-C-His)
PV271297	ABM	500 ng	EUR 723.6

Gpr81 3'UTR Luciferase Stable Cell Line
TU205392	ABM	1.0 ml	Ask for price

Gpr81 3'UTR GFP Stable Cell Line
TU255392	ABM	1.0 ml	Ask for price

Gpr81 3'UTR Luciferase Stable Cell Line
TU109042	ABM	1.0 ml	Ask for price

Gpr81 3'UTR GFP Stable Cell Line
TU159042	ABM	1.0 ml	Ask for price

GPR81 3'UTR GFP Stable Cell Line
TU059183	ABM	1.0 ml	EUR 1825.2

GPR81 3'UTR Luciferase Stable Cell Line
TU009183	ABM	1.0 ml	EUR 1825.2

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K0893205	ABM	3 x 1.0 ug	EUR 451.2

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K6130205	ABM	3 x 1.0 ug	EUR 451.2

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
K3904705	ABM	3 x 1.0 ug	EUR 451.2

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K0893206	ABM	1.0 ug DNA	EUR 200.4

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
K0893207	ABM	1.0 ug DNA	EUR 200.4

GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
K0893208	ABM	1.0 ug DNA	EUR 200.4

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K6130206	ABM	1.0 ug DNA	EUR 200.4

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K6130207	ABM	1.0 ug DNA	EUR 200.4

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
K6130208	ABM	1.0 ug DNA	EUR 200.4

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
K3904706	ABM	1.0 ug DNA	EUR 200.4

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3904707	ABM	1.0 ug DNA	EUR 200.4

Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
K3904708	ABM	1.0 ug DNA	EUR 200.4

Anti-Anti-SEPT6 antibody antibody
STJ11100949	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.

Anti-Anti-SEPT9 Antibody antibody
STJ111369	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.

Anti-Anti-SEPT11 Antibody antibody
STJ111530	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT4 Antibody antibody
STJ112276	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.

Anti-Anti-MARCH9 Antibody antibody
STJ112609	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT2 Antibody antibody
STJ25475	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT5 Antibody antibody
STJ25477	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-SEPT8 Antibody antibody
STJ25479	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT2 Antibody antibody
STJ28365	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT7 Antibody antibody
STJ28963	St John's Laboratory	100 µl	EUR 332.4
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT1 antibody antibody
STJ119580	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012]

Anti-Anti-SEPT12 Antibody antibody
STJ117759	St John's Laboratory	100 µl	EUR 332.4
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-MARCH6 Antibody antibody
STJ118549	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-MARCH6 Antibody antibody
STJ118550	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-MARCH7 Antibody antibody
STJ118752	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT3 Antibody antibody
STJ118990	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT11 Antibody antibody
STJ113941	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT11 Antibody antibody
STJ114081	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT5 Antibody antibody
STJ114819	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-MARCH8 Antibody antibody
STJ114828	St John's Laboratory	100 µl	EUR 332.4

Anti-Anti-SEPT7 Antibody antibody
STJ116214	St John's Laboratory	100 µl	EUR 332.4
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT8 Antibody antibody
STJ117206	St John's Laboratory	100 µl	EUR 332.4
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-DDB1 Antibody
A00333	BosterBio	100uL	EUR 546
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-10x96wellstestplate	Cloud-Clone	10x96-wells test plate	EUR 6777.36
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-1x48wellstestplate	Cloud-Clone	1x48-wells test plate	EUR 663.31
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-1x96wellstestplate	Cloud-Clone	1x96-wells test plate	EUR 896.16
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-5x96wellstestplate	Cloud-Clone	5x96-wells test plate	EUR 3672.72
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.

Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
4-AEA465Hu	Cloud-Clone	EUR 6837.60 EUR 3613.20 EUR 896.40	10 plates of 96 wells 5 plates of 96 wells 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.